| 1. | Theranostics in Prostate Cancer. | |
| Pages 1-8 | ||
| Zidan, L. | ||
| 2. | Role of PET/CT in Differentiated Thyroid Carcinoma. | |
| Pages 9-17 | ||
| Maamoun, N.; Moustafa, H. | ||
| 3. | How Hybrid PET/CT Improve Pitfalls and Artifacts in Malignant Lymphoma? | |
| Pages 64-81 | ||
| Moustafa, M.; Nagy A.; Gammal, M.; Badawy, A. | ||
| 4. | Prognostic Value of F-18 FDG PET/CT Volume-Based Metabolic Parameters in Patients with Cancer Esophagus. | |
| Pages 39-52 | ||
| Deif, D.; Moustafa, H.; Fathy, H.; Abougabal, A.; Elazab, M.; Elahmadawy, M. A. | ||
| 5. | Does FDG PET/CT have Additional Diagnostic Accuracy of Surveillance in Detection of Early Relapse in Non- Hodgkin Lymphoma? | |
| Pages 18-38 | ||
| Serry, O.; Moustafa, H.; El-Ghamrawy, K; Tawakol, A. | ||
| 6. | Assessment of Organ Doses for Patients undergoing 99mTc-MIBI Myocardial Perfusion Imaging. | |
| Pages 82-93 | ||
| Soli, I. A; Moussa, I.; Ali, D. A.; Kyere, AK; Hasford, F | ||
